UnitedHealth raises outlook. UnitedHealth Group stock sits 0.40 percent below Xetra close
Published on 10/21/2026 at 11:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEarnings and risk markers
- UnitedHealth lifted its adjusted 2026 earnings outlook to at least USD 20.50 per share on October 13, 2026.
- The third-quarter medical care ratio improved to 88.40 percent from 89.90 percent a year earlier.
- UnitedHealth Group stock trades at EUR 372.10 at 11:22 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.40 percent below the Xetra close of October 20, 2026.
UnitedHealth Group (ISIN US91324P1021) was trading at EUR 372.10 at Lang & Schwarz on October 21, 2026, at 11:22 a.m. CEST, down 0.40 percent versus the Xetra close of October 20, 2026. On October 13, 2026, UnitedHealth Group raised its full-year adjusted earnings outlook to at least USD 20.50 per share after reporting third-quarter results.
What improved in the quarter
The third-quarter medical care ratio was 88.40 percent, down from 89.90 percent in the third quarter of 2025. According to CNBC, the ratio also came in below the 89.90 percent expected by analysts, giving the insurer more room to convert premium revenue into earnings.
UnitedHealth reported third-quarter revenue of USD 112.69 billion, compared with USD 113.16 billion a year earlier, while operating earnings increased to USD 6.60 billion from USD 4.30 billion. Adjusted earnings per share reached USD 4.69, above the USD 4.14 consensus cited by CNBC.
Why the outlook matters
The revised outlook marked a clear change from the previous 2026 forecast of USD 19.50 to USD 20.00 per share. Reuters reported that tighter medical-cost controls and stronger Optum operations supported the increase.
The improvement was not uniform across the group. UnitedHealthcare revenue declined to USD 86.30 billion from USD 87.10 billion in the year-earlier quarter, while the company said membership in its Medicare Advantage business had fallen by 935,000 since the end of 2025.
What could still unsettle margins
Medical costs remained elevated despite the better ratio. CNBC reported that the company still faces pressure from inpatient services, specialty pharmacy drugs and the independent dispute resolution process, which management said added at least 1.00 percentage point to medical costs.
Stock trades below the Xetra close
UnitedHealth Group stock was trading at EUR 372.10 at Lang & Schwarz on October 21, 2026, at 11:22 a.m. CEST, 0.40 percent below the Xetra close of October 20, 2026 at EUR 373.60. The euro quote remained within its 52-week range of EUR 222.70 to EUR 400.60.
The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group at a glance
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 21, 2026, 11:22 a.m. CEST): EUR 372.10
- Change versus Xetra close: minus 0.40 percent
- Xetra close (October 20, 2026): EUR 373.60
- 52-week range: EUR 222.70-EUR 400.60
- Sector / Industry: Healthcare / Medical - Healthcare Plans
Market context: Market report S&P 500.
